News
-
-
PRESS RELEASE
seragy Launches with €12 Million Financing to Advance Quantitative Biomarkers for Neurodegenerative Diseases
seragy holding GmbH secures €12 million financing to advance quantitative biomarkers for neurodegenerative diseases through its SeRAS® technology, backed by Commerzbank, MBG, and the State of Lower Saxony